UK markets closed

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4080-0.0520 (-3.57%)
As of 01:48PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.08-0.06-0.29-0.29
Low estimate-0.11-0.08-0.37-0.58
High estimate-0.05-0.03-0.210.17
Year ago EPS-0.14-0.06-0.28-0.29
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate46.34M49.51M189.09M171.49M
Low estimate40.1M45.79M188.1M125.9M
High estimate56M54M191.06M198.6M
Year ago sales40.13M56.38M194.62M189.09M
Sales growth (year/est)15.50%-12.20%-2.80%-9.30%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.15-0.02-0.08-0.04
Actual EPS-0.14-0.06-0.080
Difference0.01-0.0400.04
Surprise %6.70%-200.00%0.00%100.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.08-0.06-0.29-0.29
7 days ago-0.08-0.06-0.29-0.29
30 days ago-0.09-0.05-0.27-0.08
60 days ago-0.09-0.06-0.28-0.08
90 days ago-0.09-0.06-0.29-0.05
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.42.90%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-3.60%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A